Advanced search
Publication Cover
Expert Opinion on Emerging Drugs Volume 11, 2006 - Issue 3
Submit an article Journal homepage
75
Views
12
CrossRef citations to date
0
Altmetric
Review

Emerging drugs to replace current leaders in first-line therapy for breast cancer

Michael C Cox Clinical Fellow, National Cancer Institute – National Institutes of Health, Breast Cancer Section, Medical Oncology Branch, Center for Cancer Research, Bethesda, MD, USA
,
Tu D Dan National Cancer Institute – National Institutes of Health, Medical Oncology Branch, Center for Cancer Research, 8901 Wisconsin Ave, Bldg 8, Rm 5101, Bethesda, MD, USA
&
Sandra M Swain Head, Breast Cancer Section, National Cancer Institute – National Institutes of Health, Medical Oncology Branch, Center for Cancer Research, 8901 Wisconsin Ave, Bldg 8, Rm 5101, Bethesda, MD, USA. [email protected]
Pages 489-501 | Published online: 29 Aug 2006

Citations (12)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Robyn J MacFarlane & Karen A Gelmon. (2011) Lapatinib for breast cancer: a review of the current literature. Expert Opinion on Drug Safety 10:1, pages 109-121.
Read now
Michael H Nelson & Christian R Dolder. (2007) A review of lapatinib ditosylate in the treatment of refractory or advanced breast cancer. Therapeutics and Clinical Risk Management 3:4, pages 665-673.
Read now
Rachel Suter & James A Marcum. (2007) The molecular genetics of breast cancer and targeted therapy. Biologics: Targets and Therapy 1:3, pages 241-258.
Read now
Andras G Lacko, Maya Nair, Laszlo Prokai & Walter J McConathy. (2007) Prospects and challenges of the development of lipoprotein-based formulations for anti-cancer drugs. Expert Opinion on Drug Delivery 4:6, pages 665-675.
Read now

Articles from other publishers (8)

Danilo Batista, Patrícia Campos, Valdenizia R. Silva, Luciano de S. Santos, Daniel P. Bezerra, Milena B. P. Soares, Pio Colepicolo, Leonardo Zambotti-Villela, Ernani Pinto, Floricea M. Araújo, Dirceu Martins, Luzimar G. Fernandez, Wilco Ligterink, Gisele A. B. Canuto, Martins Dias de Cerqueira & Paulo R. Ribeiro. (2019) Piper anisum as a promising new source of bioactive metabolites. Chemical Papers 74:5, pages 1505-1515.
Crossref
Arrvind Raghunath, Kunal Desai & Manmeet S. Ahluwalia. (2019) Current Treatment Options for Breast Cancer Brain Metastases. Current Treatment Options in Oncology 20:3.
Crossref
Hao Cheng & Gangliang Huang. (2018) Synthesis & antitumor activity of epothilones B and D and their analogs. Future Medicinal Chemistry 10:12, pages 1483-1496.
Crossref
Vyshak Venur & José Leone. (2016) Targeted Therapies for Brain Metastases from Breast Cancer. International Journal of Molecular Sciences 17:9, pages 1543.
Crossref
Chen Mao, Zu-Yao Yang, Ben-Fu He, Shan Liu, Jun-Hua Zhou, Rong-Cheng Luo, Qing Chen & Jin-Ling Tang. (2012) Toremifene versus tamoxifen for advanced breast cancer. Cochrane Database of Systematic Reviews 2021:2.
Crossref
Chen Mao, Ben-Fu He, Shan Liu, Jun-Hua Zhou, Li-Xin Qiu, Rong-Cheng Luo & Qing Chen. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Shinji OHNO & Monica N FORNIER. (2008) Challenging patient populations in breast cancer: Taxane resistance and triple-negative receptor subtype. Asia-Pacific Journal of Clinical Oncology 4, pages S40-S48.
Crossref
Olga Kovalchuk, Jody Filkowski, James Meservy, Yaroslav Ilnytskyy, Volodymyr P. Tryndyak, Vasyl' F. Chekhun & Igor P. Pogribny. (2008) Involvement of microRNA-451 in resistance of the MCF-7 breast cancer cells to chemotherapeutic drug doxorubicin. Molecular Cancer Therapeutics 7:7, pages 2152-2159.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.